| Autor: |
Francis CR; Department of Biological Sciences, University of Denver, Denver, CO., Bell ML; Department of Biological Sciences, University of Denver, Denver, CO., Skripnichuk MM; Department of Biological Sciences, University of Denver, Denver, CO., Kushner EJ; Department of Biological Sciences, University of Denver, Denver, CO. |
| Jazyk: |
angličtina |
| Zdroj: |
BioRxiv : the preprint server for biology [bioRxiv] 2023 Feb 22. Date of Electronic Publication: 2023 Feb 22. |
| DOI: |
10.1101/2023.02.22.529543 |
| Abstrakt: |
Clathrin-mediated endocytosis (CME) is a process vital to angiogenesis as well as general vascular homeostasis. In pathologies where supraphysiological growth factor signaling underlies disease etiology, such as in diabetic retinopathy and solid tumors, strategies to limit chronic growth factor signaling by way of CME have been shown to have tremendous clinical value. ADP ribosylation factor 6 (Arf6) is a small GTPase that promotes the assembly of actin necessary for CME. In its absence, growth factor signaling is greatly diminished, which has been shown to ameliorate pathological signaling input in diseased vasculature. However, it is less clear if there are bystander effects related to loss of Arf6 on angiogenic behaviors. Our goal was to provide a analysis of Arf6’s function in angiogenic endothelium, focusing on its role in lumenogenesis as well as its relation to actin and CME. We found that Arf6 localized to both filamentous actin and sites of CME in 2-dimensional culture. Loss of Arf6 distorted both apicobasal polarity and reduced the total cellular filamentous actin content, and this may be the primary driver underlying gross dysmorphogenesis during angiogenic sprouting in its absence. Our findings highlight that endothelial Arf6 is a potent mediator of both actin regulation and CME. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
